F.D.A. Panel Weighs MDMA Therapy and Its Risks
Briefly

The FDA is considering approving the use of MDMA, also known as Ecstasy, for the treatment of post-traumatic stress disorder (PTSD), in combination with talk therapy.
MDMA, known for fostering self-awareness, empathy, and social connectedness, is not a classic psychedelic like LSD but has shown therapeutic potential for mental health conditions.
Read at www.nytimes.com
[
]
[
|
]